Epidemiology, Treatment, and Outcomes of Gram‐Negative Bacteremia in a Multicenter Cohort of Solid Organ Transplant Recipients
Clinical Transplantation · 2025-04 · 39 (4)
DOI: 10.1111/ctr.70160 ↗At a glance
Multizentrische Studie in Clinical Transplantation, published online on 2025-04-22. Written by Sarah B Doernberg and 11 co-authors. Institution: Division of Infectious Diseases, Department of Medicine, University of California, San Francisco, California, USA. Major MEDLINE topics: Organ Transplantation, Bacteremia, Gram-Negative Bacterial Infections, Transplant Recipients. Cited 5 times so far (Crossref); 22 references. The full text is freely available (open access, CC BY-NC 4.0).
Abstract (original language)
Introduction
Little is known about the epidemiology and management of gram‐negative bloodstream infections (GN‐BSIs) in patients after solid organ transplant (SOT). We describe epidemiology, treatment approaches, and outcomes in a subset of patients with SOT from a larger cohort with GN‐BSI.
Methods
This was a multicenter, retrospective cohort study that enrolled unique, consecutive adults with GN‐BSI hospitalized at any of 24 participating hospitals between January and December 2019.
Results
Of 4581 adults in the overall cohort, 298 (6.5%) were SOT recipients, including kidney (177, 59%), liver (67, 22%), heart (23, 8%), lung (12, 4%), and multiorgan (19, 6%) recipients. The most common organisms were Escherichia coli (45%), Klebsiella pneumoniae (20%), and Pseudomonas aeruginosa (15%). Twenty‐two percent of E. coli, Klebsiella spp ., or Proteus spp . isolates had extended‐spectrum beta‐lactamase phenotype. Sixty‐six (22%) subjects did not receive active empirical therapy within the first 48 h. Median treatment duration was 15 days (IQR 12–18 days). Transition to oral therapy occurred in 161 (54%) patients at a median of 4 days (IQR 3–7 days). Thirty‐one patients (10%) had recurrent bacteremia, and 10% of the cohort died within 90 days.
Discussion
In this large cohort of SOT patients with GN‐BSI, durations exceeded 14 days in most patients, while more than half transitioned to oral antibiotics. Approximately 1 in 5 did not receive active empirical antibiotics, highlighting the impact of drug resistance and the importance of access to rapid diagnostic tools in this patient population. Mortality aligned with published estimates from other studies.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Division of Infectious Diseases, Department of Medicine, University of California, San Francisco, California, USA.
- Department of Practice, Sciences, and Health-Outcomes Research, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
- Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Division of Infectious Diseases, University of Rochester Medical Center, Rochester, New York, USA.
- Department of Pharmacy, NYU Langone Health, New York, New York, USA.
ORCID profiles: Sarah B Doernberg, Emily L Heil, David M Dobrzynski, Ryan K Shields, Erica J Stohs, Erin K McCreary
Cite
APA
Doernberg, S. B., Heil, E. L., Fiawoo, S., Lee, J. H., Cosgrove, S. E., Dobrzynski, D. M., Li, Y., Shields, R. K., Spivak, E. S., Stohs, E. J., Tamma, P. D., & McCreary, E. K. (2025). Epidemiology, Treatment, and Outcomes of Gram‐Negative Bacteremia in a Multicenter Cohort of Solid Organ Transplant Recipients. Clinical Transplantation, 39(4). https://doi.org/10.1111/ctr.70160
Vancouver
Doernberg SB, Heil EL, Fiawoo S, Lee JH, Cosgrove SE, Dobrzynski DM, et al. Epidemiology, Treatment, and Outcomes of Gram‐Negative Bacteremia in a Multicenter Cohort of Solid Organ Transplant Recipients. Clinical Transplantation. 2025;39(4). doi:10.1111/ctr.70160
BibTeX
@article{Doernberg2025,
author = {Doernberg, Sarah B and Heil, Emily L and Fiawoo, Suiyini and Lee, Jae Hyoung and Cosgrove, Sara E and Dobrzynski, David M and Li, Yihan and Shields, Ryan K and Spivak, Emily S and Stohs, Erica J and Tamma, Pranita D and McCreary, Erin K},
title = {Epidemiology, Treatment, and Outcomes of Gram‐Negative Bacteremia in a Multicenter Cohort of Solid Organ Transplant Recipients},
journal = {Clinical Transplantation},
year = {2025},
volume = {39},
number = {4},
doi = {10.1111/ctr.70160}
}
EUVIMED